Authors: MUELLER BU NELSON RP SLEASMAN J ZUCKERMAN J HEATHCHIOZZI M STEINBERG SM BALIS FM BROUWERS P HSU A SAULIS R SEI S WOOD LV ZEICHNER S KATZ TTK HIGHAM C AKER D EDGERLY M JAROSINSKI P SERCHUCK L WHITCUP SM PIZZUTI D PIZZO PA

Citation: Bu. Mueller et al., A PHASE I II STUDY OF THE PROTEASE INHIBITOR RITONAVIR IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION/, Pediatrics, 101(3), 1998, pp. 335-343

Authors: GUSTAVSON LE QIAN JX SAULIS R CARLSON GF LAU A SPERELAKIS R LAM N RINGHAM GL SOMMERVILLE KW

Citation: Le. Gustavson et al., PHARMACOKINETICS AND SAFETY OF TIAGABINE IN SUBJECTS WITH VARYING DEGREES OF HEPATIC-FUNCTION, Epilepsia, 36, 1995, pp. 159-159

Authors: CATO A QIAN JX GUSTAVSON LE SAULIS R CARLSON GF KELLY EA RINGHAM GL SOMMERVILLE KW

Citation: A. Cato et al., PHARMACOKINETICS AND SAFETY OF TIAGABINE IN SUBJECTS WITH VARIOUS DEGREES OF RENAL-FUNCTION, Epilepsia, 36, 1995, pp. 159-159

Authors: SAMARA E GRANNEMAN R SAULIS R WITT G

Citation: E. Samara et al., PHARMACOKINETIC-PHARMACODYNAMIC INTERACTION BETWEEN VALPROATE AND LORAZEPAM, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 153-153